Suppressing Puberty Not Tied to Higher Sexual Dysfunction in Trans Adults, Small Study Finds
The first of its kind, this survey study of 70 Dutch adults who received puberty blockers and cross-sex hormones as minors calls into question one of the top criticisms of such pediatric treatment.
A small survey study of Dutch transgender adults group who as minors received puberty blockers and cross-sex hormones to treat gender dysphoria has found that rates of sexual satisfaction and dysfunction among them are not substantially different from trans people who started hormones as adults.
Aside from being based on only 70 people, the study, which was published Tuesday in The Journal of Sexual Medicine, has various notable limitations. So its findings are hardly definitive. But as the first study of its kind, it sheds at least some light on a prevailing mystery about the long-term impacts of pediatric gender-transition treatment. And it calls into question one of the primary arguments against the use of these drugs in minors: that they can lead to lifelong sexual dysfunction.
The rates of sexual satisfaction and dysfunction among the survey members were not perfect by any means. Despite having too few respondents to conduct a proper statistical analysis to back this c…
Keep reading with a 7-day free trial
Subscribe to Hazard Ratio: Benjamin Ryan to keep reading this post and get 7 days of free access to the full post archives.